Fareston tablets 40 mg for breast cancer
Product Code :
Availability : 7
General information on Japanese tablets Fareston 40 mg for breast cancer
Package details: 40 tablets
Manufacturer: Nippon Kayaku, Japan
Active ingredient: toremifene citrate (chemical formula C32H36ClNO8)
Medical effect: Fareston tablets work as selective estrogen receptor modulator. It inhibits activity of estrogen against breast cancer cells and suppresses the growth of cancer cells.
Contraindications and precautions: Fareston tablets cannot be used for the following categories of patients:
- patients with myelosuppression,
- patients with hypokalemia,
- patients with arrhythmia such as bradycardia or cardiac disease which is prone to develop arrhythmia such as myocardial ischemia,
- patients with history of QT prolongation on electrocardiogram.
- patients taking antiarrhythmic agent (quinidine, procainamide, amiodarone, sotalol, etc.),
- pregnant or breastfeeding women.
Dosage and administration of Japanese tablets Fareston for breast cancer
Take 1 tablet (40 mg of toremifene) 1 time a day. If the patient has already received drug treatment or radiation therapy, take 3 tablets (120 mg of toremifene) 1 time a day.
Be sure to use birth control other than hormone preparation as Fareston tablets reduce the efficacy of estrogen.
How effective are Fareston tablets 40 mg from Japan for breast cancer?
Fareston tablets work as selective estrogen receptor modulator, preventing estrogen signals from getting to breast cancer cells. This action effectively suppresses the growth of cancer cells. Also, Fareston tablets significantly reduce breast pain, allowing to decrease using pain-killers.
Who should use Fareston tablets 40 mg from Japan for breast cancer?
Japanese tablets Fareston 40 mg can be used for the treatment of breast cancer in both early stage and metastatic stage. This medicine is especially effective for postmenopausal women with estrogen receptor-positive or unknown-status tumors. Studies proved it’s effective, safe, well-tolerated and less likely to cause uterine neoplasms, serious vascular events (M. Mustonen, S. Pyrhönen, and P.-L. Kellokumpu-Lehtinen. Toremifene in the treatment of breast cancer. World Journal of Clinical Oncology, 2014 Aug 10; 5(3): 393–405).
Also, Fareston tablets are used for decreasing the risk of bone fractures in men with prostate cancer or for improving sperm parameters in men with idiopathic oligozoospermia.